Yanqi Li
Key Laboratory Of Cancer Prevention And Therapy, Huanhu West Road
Dayingmen, China
Dayingmen, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Metal-organic frameworks as versatile geobacter platforms for microbial protection and functionalization.
Journal: Biotechnology advances
Published: October 08, 2025
Comparison of dynamic changes in the peripheral CD8+ T cells function and differentiation in ESCC patients treated with radiotherapy combined with anti-PD-1 antibody or concurrent chemoradiotherapy.
Journal: Frontiers in immunology
Published: October 03, 2022
Immunotherapy with or without radiotherapy for metastatic or recurrent esophageal squamous cell carcinoma: A real-world study.
Journal: Clinical and translational radiation oncology
Published: August 08, 2022
Prognostic values of the gross volume of metastatic lymph nodes in patients with esophageal squamous cell carcinoma treated with definitive concurrent chemoradiotherapy.
Journal: Frontiers in oncology
Published: July 17, 2022
Radiotherapy plus camrelizumab affects peripheral CD8 T-cell differentiation subsets expressing PD-1, TIGIT, and CTLA-4 in esophageal squamous cell carcinoma.
Journal: Journal of leukocyte biology
Published: March 22, 2022
Effects on the crystallization behavior and biocompatibility of poly(LLA-ran-PDO-ran-GA) with poly(d-lactide) as nucleating agents.
Journal: RSC advances
Published: January 25, 2022
A Clinical Scoring Model to Predict the Effect of Induction Chemotherapy With Definitive Concurrent Chemoradiotherapy on Esophageal Squamous Cell Carcinoma Prognosis.
Journal: Frontiers in oncology
Published: April 30, 2021
Showing 1-8 of 8
Last Updated: 09/26/2026